NLRP3 and cryopyrin-associated periodic syndrome: The inflammasome inhibition by 4-OI was also confirmed in other two pathogenic NLRP3 variants, p.R262W and p.T350M, which together with the p.D305N variant, cover the clinical spectra of CAPS.